dna microarray capitalbio (CapitalBio Corporation)
90
Structured Review
CapitalBio Corporation
dna microarray capitalbio

Dna Microarray Capitalbio, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/capitalbio++dna+microarray/pmc08339777-99-6-8
Average 90 stars, based on 1 article reviews

Dna Microarray Capitalbio, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/capitalbio++dna+microarray/pmc08339777-99-6-8
Average 90 stars, based on 1 article reviews
dna microarray capitalbio - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis"
Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
Journal: Journal of Thoracic Disease
doi: 10.21037/jtd-21-913
Figure Legend Snippet: The ROC curve of the CapitalBio DNA microarray for detecting RFP resistance. ROC, receiver operating characteristic; RFP, rifampicin.
Techniques Used: Microarray
Figure Legend Snippet: Diagnostic performance of DNA microarray for RFP resistance
Techniques Used: Diagnostic Assay, Microarray
Figure Legend Snippet: The ROC curve of the CapitalBio DNA microarray for detecting INH resistance. ROC, receiver operating characteristic; IHN, isonicotinic acid hydrazide.
Techniques Used: Microarray
Figure Legend Snippet: Diagnostic performance of DNA microarray for INH resistance
Techniques Used: Diagnostic Assay, Microarray
Related Articles
Microarray:Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: .. The CapitalBio™ Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: .. Overall, the CapitalBio™ Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: .. Clinical specimens (e.g., pus, caseous or granulation tissue) were collected during surgery and were divided into two aliquots for tuberculosis detection; one of the aliquots was subjected to species identification and detection of gene mutations by the Article Title: Current approaches and developments in transcript profiling of the human placenta Article Snippet: 2019 , NCBI GEO GSE102897 , Agilent-078298 human ceRNA array V1.0 4X180K , Microarray , Tissue , Chorionic villi , 12 (pooled in pairs) −6 C −6 PE , 3rd trimester , PE vs controls , Hu et al. (2018a ) . .. , Not publically available, but available on request , Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: .. Specimens collected during surgery from the tuberculosis patients were subjected to M. tuberculosis species identification and drug-resistance detection by the CapitalBio™ Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: Recently, a multitude of commercial molecular DST kits, such as INNO-LiPA, Genotype MDR-TBplus, CapitalBio™ DNA microarray and Xpert MTB/RIF, have been developed for the detection of mutations associated with resistance to RMP and INH [ - ]. .. Among them, the Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: Specimens collected during surgery from the tuberculosis patients were subjected to M. tuberculosis species identification and drug-resistance detection by the CapitalBio™ DNA microarray, and results were compared with those obtained from the absolute concentration drug susceptibility testing. .. The CapitalBio™ Article Title: Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview. Article Snippet: Despite available global efforts and funding, Tuberculosis (TB) continues to affect a considerable number of patients worldwide.. Policy makers and stakeholders set clear goals to reduce TB incidence and mortality, but the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) complicate the reach of these goals.. Drug-resistance TB needs to be diagnosed rapidly and accurately to effectively treat patients, prevent the transmission of MDR-TB, minimise mortality, reduce treatment costs and avoid unnecessary hospitalisations. Concentration Assay:Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study Article Snippet: .. Specimens collected during surgery from the tuberculosis patients were subjected to M. tuberculosis species identification and drug-resistance detection by the CapitalBio™ |